Australia's largest stock trading and investment forum Australia's #1 stock forum

AVR

Click for more information

0.00%

$12.90 anteris technologies ltd

Most undervalued stock, page-231

First 231 Last

Share
Profile

Follow
lexcorp

8,034 Posts.

523

30/11/16

12:35

Post #: 20992688
Share

Originally posted by ashtool ↑

Objective: reduce community % rate of infected HSV-2 individuals.

How: develop a vaccine that can reduce the chance of infection/spreading for both non-infected and infected individuals.

* Reduction in outbreaks is vital, as that is when the virus is most transmittable/active.
* Reduction is shedding is vital, as that is where the majority of transmission occurs unwittingly.
* Admedus' vaccine is interesting, as it can be applied to both infected and non-infected individuals, and obtain a benefit for both. Uninfected people will presumably build a level of immunity (although, not 100%) and infected people will reduce their transmit-ability somewhat.

This approach should statistically reduce the spread/level of HSV-2 within the community?

Not eradication - but improvement.

The other vaccines/scientists getting a lot of attention for their vaccine (RVx Rational Vaccine, etc) are getting their attention via PR firms - not due to the results.

As far as I can see, Admedus has the best reduction in shedding (58%) (although, I note Genoca now also quoting 58% for their vaccine in some places........) and the certain best in outbreaks at 90%.

Something in the technology is working. I suspect it can be improved upon.

Cheers

Expand

Spot on.

AHZ Price at posting: 36.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

ALR

Altair Minerals hits high-grade copper and gold at Wee MacGregor, QLD

WMG

Western Mines identifies 2 high-grade zones at Mulga Tank in WA

ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024

CXU

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

There are more pages in this discussion • 38 more messages in this thread...

First 231 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $12.90		Change 0.000(0.00%)		Mkt cap ! $272.6M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	2000	$12.70

Sellers (Offers)

Price($)	Vol.	No.
$13.25	100	1

View Market Depth

No.	Vol.	Price($)
1	2000	12.700
1	800	12.500
1	60	12.250
1	85	11.620
1	1500	11.610

Price($)	Vol.	No.
13.250	100	1
13.440	246	1
13.450	73	1
13.500	750	1
13.670	366	1

Last trade - 09.30am 18/09/2024 (20 minute delay)

AVR (ASX) Chart

Day chart unavailable